NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (enExample) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (enExample) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (enExample)
CA (1) CA1040619A (enExample)
DE (1) DE2330342A1 (enExample)
DK (1) DK136157B (enExample)
FR (1) FR2189034B2 (enExample)
GB (1) GB1434919A (enExample)
LU (1) LU67790A1 (enExample)
NL (1) NL7308267A (enExample)
ZA (1) ZA734037B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (en) 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.

Also Published As

Publication number Publication date
BE800899R (fr) 1973-12-14
LU67790A1 (enExample) 1973-08-16
DE2330342A1 (de) 1974-01-17
GB1434919A (en) 1976-05-12
CA1040619A (en) 1978-10-17
AU5693773A (en) 1974-12-19
FR2189034B2 (enExample) 1977-01-21
DK136157B (da) 1977-08-22
DK136157C (enExample) 1978-01-23
FR2189034A2 (enExample) 1974-01-25
ZA734037B (en) 1974-05-29

Similar Documents

Publication Publication Date Title
DK136157C (enExample)
DK134525C (enExample)
JPS4992297A (enExample)
JPS498443U (enExample)
JPS5113281B2 (enExample)
JPS5516929B2 (enExample)
JPS5623717B2 (enExample)
JPS4980097U (enExample)
JPS49111475U (enExample)
JPS48108566U (enExample)
CS151852B1 (enExample)
JPS4989393U (enExample)
JPS4956249U (enExample)
CH591768A5 (enExample)
CH565177A5 (enExample)
CH568902A5 (enExample)
AU480549A (enExample)
CH593983A5 (enExample)
AU481007A (enExample)
CH568205A5 (enExample)
CH585779A5 (enExample)
BG18250A1 (enExample)
CH594644A5 (enExample)
CH595333A5 (enExample)
CH567197A5 (enExample)

Legal Events

Date Code Title Description
BV The patent application has lapsed